Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1215857.RAsQ--XvDduijC7JQLTA4B7OHgWUzYlF-9ap2YgwPbIqs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1215857.RAsQ--XvDduijC7JQLTA4B7OHgWUzYlF-9ap2YgwPbIqs130_assertion type Assertion NP1215857.RAsQ--XvDduijC7JQLTA4B7OHgWUzYlF-9ap2YgwPbIqs130_head.
- NP1215857.RAsQ--XvDduijC7JQLTA4B7OHgWUzYlF-9ap2YgwPbIqs130_assertion description "[These include strategies targeting chemokine pathways via CC chemokine receptors 1 and 2 to modulate the inflammatory response, inhibition of phosphodiesterase to restore nitric oxide-cyclic 3',5'-guanosine monophosphate function, inhibition of nicotinamide adenine dinucleotide phosphate oxidase 1 and 4 to suppress reactive oxygen species production, and inhibition of endothelin 1 or tumor necrosis factor ? to ameliorate progressive renal fibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215857.RAsQ--XvDduijC7JQLTA4B7OHgWUzYlF-9ap2YgwPbIqs130_provenance.
- NP1215857.RAsQ--XvDduijC7JQLTA4B7OHgWUzYlF-9ap2YgwPbIqs130_assertion evidence source_evidence_literature NP1215857.RAsQ--XvDduijC7JQLTA4B7OHgWUzYlF-9ap2YgwPbIqs130_provenance.
- NP1215857.RAsQ--XvDduijC7JQLTA4B7OHgWUzYlF-9ap2YgwPbIqs130_assertion SIO_000772 25176603 NP1215857.RAsQ--XvDduijC7JQLTA4B7OHgWUzYlF-9ap2YgwPbIqs130_provenance.
- NP1215857.RAsQ--XvDduijC7JQLTA4B7OHgWUzYlF-9ap2YgwPbIqs130_assertion wasDerivedFrom befree-2016 NP1215857.RAsQ--XvDduijC7JQLTA4B7OHgWUzYlF-9ap2YgwPbIqs130_provenance.
- NP1215857.RAsQ--XvDduijC7JQLTA4B7OHgWUzYlF-9ap2YgwPbIqs130_assertion wasGeneratedBy ECO_0000203 NP1215857.RAsQ--XvDduijC7JQLTA4B7OHgWUzYlF-9ap2YgwPbIqs130_provenance.